Evidence map›Paper›PMID 41407990›Full record

ArticleClinical and experimental medicine2025

Correction: Capmatinib for the treatment of METex14 skipping non-small cell lung cancer: retrospective analysis of real-world data from patients receiving compassionate use treatment in Italy.

Fabiana Letizia Cecere, Ettore D'Argento, Francesco Gelsomino, Francesco Pesola, Paolo Bironzo, Salvatore Grisanti, Laura Bonanno, Gianluca Spitaleri, Diletta Valsecchi, Ilaria Marcon and 1 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical and experimental medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Fabiana Letizia CecereMedical Oncology 2, IRCCS Regina Elena National Cancer Institute Rome, Rome, Italy.
Ettore D'ArgentoComprehensive Cancer Center, Medical Oncology Department, Fondazione Policlinico, Universitario Agostino Gemelli IRCCS, Rome, Italy.ORCID http://orcid.org/0000-0001-8802-9876
Francesco GelsominoMedical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.ORCID http://orcid.org/0000-0002-9204-1728
Francesco PesolaThoracic Oncology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.ORCID http://orcid.org/0000-0001-7735-8973
Paolo BironzoDepartment of Oncology, University of Torino, AOU S. Luigi Gonzaga, Orbassano, Italy.ORCID http://orcid.org/0000-0002-2784-5076
Salvatore GrisantiMedical Oncology, ASST Spedali Civili di Brescia, University of Brescia, Brescia, Italy.ORCID http://orcid.org/0000-0001-6922-1934
Laura BonannoDepartment of Surgery, Oncology and Gastroenterology, University of Padova, Padua, Italy.ORCID http://orcid.org/0000-0001-5218-4970
Gianluca SpitaleriThoracic Oncology Division, European Institute of Oncology IRCCS, Via Ripamonti, 435, 20141, Milan, Italy.ORCID http://orcid.org/0000-0003-3742-9962
Diletta ValsecchiNovartis Farma SpA, Milan, Italy.ORCID http://orcid.org/0009-0009-3268-0876
Ilaria MarconNovartis Farma SpA, Milan, Italy.ORCID http://orcid.org/0009-0001-1363-899X
Diego CortinovisMedical Oncology Fondazione, IRCCS San Gerardo dei Tintori Monza, Via Pergolesi 33, 20900, Monza, Italy. diegoluigi.cortinovis@irccs-sangerardo.it.ORCID http://orcid.org/0000-0001-7611-7369

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41407990
PMCPMC12712094

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.